select trial semaglutide The SELECT Trial - A

Ipamorelin Ipamorelin is a selective growth hormone secretagogue studied for its role in stimulating natural growth hormone release through ghrelin receptor activation

It belongs to the GHRP (Growth Hormone Releasing Peptide) family but is considered one of the most selective and well-tolerated options available today

These trials will be decisive Phase 2 results are promising but involve smaller samples and shorter follow-up than what regulators require for approval decisions

Important Note Weight loss injections require ongoing use for sustained effects discontinuation typically results in weight regain within 12-18 months as appetite regulation returns to baseline patterns